You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mavrilimumab

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Sars-CoV2, Pneumonia Trial in Richmond (Mavrilimumab, Placebos)

Completed
Has Results
  • COVID-19
  • +2 more
  • Mavrilimumab
  • Placebos
  • Richmond, Virginia
    Virginia Commonwealth University
Aug 4, 2021

COVID 19, SARS-CoV 2, Pneumonia Trial in Weston, Cleveland (Mavrilimumab, Placebos)

Completed
Has Results
  • COVID 19
  • +2 more
  • Mavrilimumab
  • Placebos
  • Weston, Florida
  • +1 more
May 11, 2021

COVID Trial in Worldwide (mavrilimumab, Placebo)

Completed
  • COVID
  • mavrilimumab
  • Placebo
  • Los Angeles, California
  • +31 more
Sep 21, 2022

Giant Cell Arteritis Trial in Worldwide (mavrilimumab, , prednisone)

Completed
  • Giant Cell Arteritis
  • mavrilimumab
  • +2 more
  • Sarasota, Florida
  • +46 more
Aug 30, 2021

Rheumatoid Arthritis Trial in Worldwide (Mavrilimumab 10 mg, Mavrilimumab 30 mg, Mavrilimumab 50 mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • Mavrilimumab 10 mg
  • +4 more
  • Plovdiv, Bulgaria
  • +55 more
Mar 23, 2018

Rheumatoid Arthritis Trial in Worldwide (Mavrilimumab 100 mg)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Mavrilimumab 100 mg
  • Ciudad Autonoma Buenos Aires, Argentina
  • +52 more
May 30, 2017

Rheumatoid Arthritis Trial in Worldwide (Mavrilimumab 30 mg, Mavrilimumab 100 mg, Mavrilimumab 150 mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • Mavrilimumab 30 mg
  • +3 more
  • Ciudad Autonoma de Buenos Aire, Argentina
  • +42 more
Aug 3, 2016

Rheumatoid Arthritis Trial in Worldwide (Golimumab 50 mg, Mavrilimumab 100 mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • Golimumab 50 mg
  • Mavrilimumab 100 mg
  • Ciudad Autonoma Buenos Aires, Argentina
  • +38 more
Sep 12, 2016

Healthy Volunteers Trial in London (100mg Mavrilimumab, 150mg mavrilimumab, Placebo)

Completed
  • Healthy Volunteers
  • 100mg Mavrilimumab
  • +2 more
  • London, United Kingdom
    Research Site
Jan 8, 2015

Rheumatoid Arthritis Trial in Berlin (CAM-3001, Placebo)

Completed
  • Rheumatoid Arthritis
  • Berlin, Germany
    Charite Research Organization GmbH
Jul 19, 2012